Sexual Health, Quality of Life, and Fertility Counselling in Breast Cancer Survivors Younger than 40 Years

Read the full article See related articles

Discuss this preprint

Start a discussion What are Sciety discussions?

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Background: Young women treated for breast cancer may continue to experience sexual and reproductive problems after treatment. These issues are not always addressed in routine follow-up. We evaluated sexual health, quality of life, and fertility-related counselling in breast cancer survivors younger than 40 years. Methods: We performed a single-centre cross-sectional study including 65 women with non-metastatic breast cancer who had completed primary treatment at least 12 months earlier. Patients completed the EORTC QLQ-C30 and SHQ-22 questionnaires and an additional questionnaire on fertility preservation. Results: Overall quality-of-life scores were relatively preserved, although several domains remained affected, especially physical and role functioning, fatigue, and insomnia. Sexual problems were common, particularly low libido, vaginal dryness, treatment-related impairment of sexual life, and limited communication with healthcare professionals. Women receiving endocrine therapy reported poorer physical, emotional, and cognitive functioning, together with a higher symptom burden and more sexual complaints. Thirty-nine patients (60%) reported receiving information on fertility preservation before treatment, but only 11 underwent a fertility preservation procedure. Women who had undergone fertility preservation reported higher sexual activity scores. Conclusions: In this cohort of young breast cancer survivors, sexual difficulties remained frequent more than one year after completion of treatment, even when overall quality-of-life scores appeared relatively preserved. Fertility counselling was also not uniformly reported. These findings suggest that sexual health and reproductive issues should be addressed more consistently during follow-up care, especially in women receiving endocrine therapy.

Article activity feed